Prelack Steven 4
4 · Aerpio Pharmaceuticals, Inc. · Filed Jun 22, 2018
Insider Transaction Report
Form 4
Prelack Steven
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-20+21,400→ 21,400 totalExercise: $4.00Exp: 2028-06-20→ Common Stock (21,400 underlying)
Footnotes (1)
- [F1]Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time.